Research and Markets: China Blood Products Industry Report, 2007-2008 Out Now
2009-01-09 17:07:01 -
Research and Markets (www.researchandmarkets.com/research/8ce446/china_blood_produc) has announced the addition of the "China Blood Products Industry Report, 2007-2008" report to their offering.
China blood products industry is all along comparatively independent from global blood products industry. In the year of 1986, according to the rules from Ministry of Health, China prohibited the import of blood products except HAS. However, since 2002, HAS import had been also prohibited from BSE disease regions.
Considering the short supply of domestic blood products, in May 2008, State Council of China adjusted the import tariff of HSA products from 3% to zero during 1st Jun 2008 to the end of Dec 2008. However, due to the HAS price in China market lower than international market, foreign companies are seldom willing to export.
China has totally 33 blood products manufacturers. In the year of 2007, the blood products market scale in China was about CNY 6 billion. China has a great demand for albumin, due to the large number of liver disease patients; the other blood products also have a considerable demand in China such as gammaglobulin, immunoglobulin and plasma thromboplastin component.
Based on the authoritative statistics from General Administration of China Customs, Pharmaceutical Industry Association and National Bureau of Statistics, this report is focused on the actuality of China blood products industry, as well as its development trend and investment opportunities and risks.
Key Topics Covered:
- 1. Overview of China Blood Products Industry
- 2. China Blood Plasma Market
- 3. Development of Global Blood Products Industry
- 4. Key Blood Products
- 5. Key Manufacturers in China
- 6. Investment Analysis
- Executive Summary
Companies Mentioned:
- Hualan Biological Engineering Co., Ltd
- Shanghai RAAS Blood Products Co., Ltd
- Shanghai Institute of Biological Products
- Chengdu Rongsheng Pharmaceuticals Co., Ltd
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd
- Guiyang Qianfeng Biological Product Liability Co., Ltd.
For more information visit www.researchandmarkets.com/research/8ce446/china_blood_produc.
Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
